SHANGHAI, June 4, 2023 /PRNewswire/ — This was a Phase 2, double-masked, randomized, vehicle-controlled, dose-response study to assess the safety and ocular hypotensive efficacy of VVN539 in subjects with primary open angle glaucoma (POAG) or ocular hypertension (OHT). The primary…
Month: June 2023
ROCKVILLE, Md. and SUZHOU, China, June 4, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic,…
AI Set off a Wave of High-Performance Computing COMPUTEX Returned to Glory TAIPEI, Taiwan, June 4, 2023 /PRNewswire/ — The 2023 COMPUTEX successfully concluded on June 2, the first physical exhibition after the border was opened, attracting a huge crowd of visitors. During the 4-day…
SAN FRANCISCO, June 4, 2023 /PRNewswire/ — Vial, a global tech-first CRO providing next-generation clinical trial management services, announced it will be sponsoring and presenting at the 2023 Clinical Trials at the Summit (CTS) in Park City, UT, Saturday, June 10. CTS 2023 will be…